For the twelve months ended Jun 30, 2026, Astrana Health Inc. reported $3.84B of revenue and $40.55M of net income.
ASTH revenue was $972.52M in fiscal Q2 2026 (ended Jun 30, 2026), up 48.5% from a year earlier and up 0.8% from the prior quarter. For the full fiscal 2025 it was $3.18B, up 56.4% from fiscal 2024. Compound annual growth was +35.9% over 5 years. It rose in each of the last 8 fiscal years. Fiscal 2025 is the highest of the 14 fiscal years on file.
ASTH net income was $19.74M in fiscal Q2 2026 (ended Jun 30, 2026), up 109.5% from a year earlier and up 36.7% from the prior quarter. For the full fiscal 2025 it was $22.49M, down 47.9% from fiscal 2024. Compound annual growth was -9.8% over 5 years. It rose in 4 of the last 8 fiscal years.
ASTH diluted EPS was $0.40 in fiscal Q2 2026 (ended Jun 30, 2026), up 110.5% from a year earlier and up 37.9% from the prior quarter. For the full fiscal 2025 it was $0.46, down 48.9% from fiscal 2024. Compound annual growth was -14.6% over 5 years.
ASTH free cash flow was $28.87M in fiscal Q2 2026 (ended Jun 30, 2026), down 67.7% from a year earlier and down 54.9% from the prior quarter. For the full fiscal 2025 it was $104.49M, up 136.6% from fiscal 2024. Compound annual growth was +18.4% over 5 years. It rose in 5 of the last 8 fiscal years. Fiscal 2025 is the highest of the 14 fiscal years on file.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $773.91M | $687.18M | $560.62M | $519.91M | $356.36M | $32.99M |
| Cost of revenue | - | - | - | - | $596.14M | $539.21M | $467.81M | $361.13M | $273.45M | $22.07M |
| Gross profit | - | - | - | - | $177.77M | $147.97M | $92.81M | $158.78M | $82.90M | $10.92M |
| Selling, general and admin | $217.26M | $154.11M | $112.60M | $77.67M | $62.08M | $49.12M | $41.48M | $43.35M | $26.25M | $11.28M |
| Operating income | $78.53M | $89.35M | $84.61M | $104.27M | $98.18M | $80.50M | $32.42M | $88.43M | $35.15M | -$694.3K |
| Interest expense | $49.93M | $33.10M | $16.10M | $7.92M | $5.39M | $9.50M | $4.73M | $561.0K | $79.7K | $1.33M |
| Pre-tax income | $39.61M | $80.82M | $89.84M | $86.62M | $77.75M | $178.43M | $25.84M | $82.63M | $49.71M | -$1.18M |
| Income tax | $15.53M | $30.89M | $31.99M | $40.88M | $31.69M | $56.34M | $8.17M | $22.36M | $3.89M | $163.8K |
| Net income | $22.49M | $43.15M | $60.72M | $45.17M | $68.92M | $37.69M | $14.12M | $10.84M | $25.80M | -$1.80M |
| EPS, basic | $0.46 | $0.91 | $1.30 | $1.00 | $1.57 | $1.03 | $0.41 | $0.33 | $1.01 | -$0.37 |
| EPS, diluted | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | -$0.37 |
| Diluted shares | 49.4M | 48.0M | 46.9M | 45.6M | 45.4M | 37.4M | 36.4M | 37.9M | 28.7M | 4.9M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $429.47M | $289.10M | $293.81M | $288.03M | $233.10M | $193.97M | $104.01M | $107.64M | $118.50M | $5.01M |
| Short-term investments | - | $2.38M | $2.50M | $5.57M | $53.42M | $67.69M | $116.54M | $1.13M | $1.14M | - |
| Receivables | $374.46M | $275.99M | - | $49.63M | $10.61M | $7.06M | $11.00M | $7.73M | $7.60M | $3.80M |
| Current assets | $863.31M | $638.50M | $461.51M | $428.13M | $404.46M | $338.58M | $329.07M | $172.86M | $144.16M | $9.85M |
| Goodwill | $865.30M | $419.25M | $278.83M | $269.05M | $246.42M | $232.43M | $238.50M | $185.81M | $189.85M | $2.17M |
| Total assets | $2.22B | $1.35B | $933.36M | $966.21M | $867.36M | $817.49M | $728.71M | $513.00M | $490.64M | $15.00M |
| Current liabilities | $615.27M | $365.61M | $218.67M | $148.61M | $114.72M | $114.99M | $105.42M | $72.02M | $109.60M | $5.97M |
| Short-term debt | $47.87M | $9.38M | $19.50M | $619.0K | $780.0K | $10.89M | $9.50M | $0 | - | - |
| Long-term debt | $990.90M | $425.30M | $258.94M | $203.39M | $182.92M | $230.21M | $232.17M | $0 | - | $1.46M |
| Total debt | $1.04B | $434.67M | $278.44M | $204.01M | $183.70M | $241.10M | $241.67M | $0 | - | $1.46M |
| Total liabilities | $1.66B | $840.73M | $522.59M | $407.67M | $356.72M | $372.34M | $367.65M | $106.34M | $154.32M | $15.99M |
| Shareholders' equity | $779.29M | $716.73M | $616.65M | $544.31M | $454.11M | $329.46M | $192.34M | $181.54M | $164.18M | -$990.2K |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $114.60M | $52.20M | $68.23M | $82.13M | $70.33M | $46.16M | $13.67M | $25.50M | $51.83M | -$271.9K |
| Capital expenditures | $10.11M | $8.03M | $28.53M | $22.94M | $19.22M | $1.16M | $1.04M | $1.17M | $2.08M | $44.5K |
| Free cash flow | $104.49M | $44.17M | $39.70M | $59.19M | $51.11M | $45.00M | $12.63M | $24.33M | $49.75M | -$316.4K |
| Investing cash flow | -$539.00M | -$192.40M | -$65.52M | -$7.11M | $16.54M | $95.49M | -$180.63M | -$25.18M | $26.72M | -$3.20M |
| Financing cash flow | $569.35M | $135.15M | $3.42M | -$20.09M | -$47.75M | -$51.70M | $163.33M | -$11.18M | -$14.98M | $1.66M |
| Dividends paid | $7.88M | $4.04M | $62.07M | $14.03M | $31.09M | $51.32M | $61.72M | $17.76M | $10.45M | - |
| Share repurchases | $25.60M | $900.0K | $10.19M | $9.25M | $5.74M | $537.0K | $7.57M | $5.05M | $3.18M | $500 |
| Stock-based compensation | $38.60M | $34.54M | $22.04M | $16.10M | $6.75M | $3.38M | $1.55M | $1.44M | $2.74M | - |
| Depreciation and amortization | $45.75M | $27.93M | $17.75M | $17.54M | $17.52M | $18.35M | $18.28M | $19.30M | $19.08M | $334.4K |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 56.4% | 46.7% | 21.2% | 47.8% | 12.6% | 22.6% | 7.8% | 45.9% | - | 214.7% |
| Net income growth, YoY | -47.9% | -28.9% | 34.4% | -34.5% | 82.9% | 167.0% | 30.3% | -58.0% | - | - |
| EPS growth, YoY | -48.9% | -30.2% | 30.3% | -34.9% | 50.5% | 159.0% | 34.5% | -67.8% | - | - |
| Gross margin | - | - | - | - | 23.0% | 21.5% | 16.6% | 30.5% | 23.3% | 33.1% |
| Operating margin | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% | 11.7% | 5.8% | 17.0% | 9.9% | -2.1% |
| Net margin | 0.7% | 2.1% | 4.4% | 3.9% | 8.9% | 5.5% | 2.5% | 2.1% | 7.2% | -5.5% |
| Free cash flow margin | 3.3% | 2.2% | 2.9% | 5.2% | 6.6% | 6.5% | 2.3% | 4.7% | 14.0% | -1.0% |
| Return on equity | 2.9% | 6.0% | 9.8% | 8.3% | 15.2% | 11.4% | 7.3% | 6.0% | 15.7% | - |
| Return on assets | 1.0% | 3.2% | 6.5% | 4.7% | 7.9% | 4.6% | 1.9% | 2.1% | 5.3% | -12.0% |
| Current ratio | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 | 2.94 | 3.12 | 2.40 | 1.32 | 1.65 |
| Debt to equity | 1.33 | 0.61 | 0.45 | 0.37 | 0.40 | 0.73 | 1.26 | 0.00 | - | - |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $972.52M | $965.10M | $950.53M | $956.05M | $654.81M | $620.39M | $665.21M | $478.71M | $486.26M | $404.36M | $353.04M | $348.17M |
| Selling, general and admin | $54.15M | $61.74M | $60.25M | $62.39M | $50.73M | $43.90M | $41.63M | $37.80M | $35.95M | $38.72M | $37.95M | $29.41M |
| Operating income | $34.32M | $28.53M | $18.39M | $19.21M | $20.34M | $20.58M | $720.0K | $28.43M | $30.07M | $30.14M | -$3.87M | $39.08M |
| Interest expense | $16.00M | $16.10M | $17.52M | $17.72M | $7.38M | $7.31M | $8.07M | $8.86M | $8.59M | $7.58M | $5.42M | $3.78M |
| Pre-tax income | $27.21M | $19.71M | $7.51M | $5.67M | $16.82M | $9.60M | -$1.90M | $26.81M | $31.90M | $24.00M | $924.0K | $38.02M |
| Income tax | $8.76M | $6.58M | $944.0K | $4.59M | $6.61M | $3.38M | $5.88M | $7.83M | $10.03M | $7.14M | $1.02M | $10.04M |
| Net income | $19.74M | $14.44M | $6.00M | $373.0K | $9.42M | $6.69M | -$6.95M | $16.09M | $19.17M | $14.84M | $12.36M | $22.06M |
| EPS, basic | $0.40 | $0.30 | $0.12 | $0.01 | $0.19 | $0.14 | -$0.14 | $0.34 | $0.40 | $0.31 | $0.27 | $0.47 |
| EPS, diluted | $0.40 | $0.29 | $0.12 | $0.01 | $0.19 | $0.14 | -$0.14 | $0.33 | $0.40 | $0.31 | $0.26 | $0.47 |
| Diluted shares | 49.8M | 49.1M | - | 49.5M | 49.5M | 48.9M | - | 48.2M | 48.0M | 47.7M | - | 46.9M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $400.79M | $478.38M | $429.47M | $462.23M | $339.70M | $258.52M | $289.10M | $347.99M | $325.31M | $334.80M | $293.81M | $273.94M |
| Short-term investments | - | - | - | $1.22M | $2.42M | $2.40M | $2.38M | $2.35M | $2.38M | $2.49M | $2.50M | $3.02M |
| Receivables | $465.08M | $467.39M | $374.46M | $381.21M | $348.73M | - | $275.99M | - | - | - | - | - |
| Current assets | $919.16M | $1.00B | $863.31M | $883.63M | $729.15M | $613.27M | $638.50M | $596.99M | $570.35M | $538.81M | $461.51M | $476.23M |
| Goodwill | $887.00M | $874.80M | $865.30M | $863.27M | $416.92M | $416.39M | $419.25M | $409.71M | $409.58M | $410.27M | $278.83M | $275.53M |
| Total assets | $2.28B | $2.36B | $2.22B | $2.24B | $1.44B | $1.33B | $1.35B | $1.29B | $1.25B | $1.23B | $933.36M | $1.07B |
| Current liabilities | $747.64M | $745.37M | $615.27M | $629.93M | $459.75M | $361.27M | $365.61M | $312.93M | $309.82M | $355.27M | $218.67M | $202.96M |
| Short-term debt | $53.85M | $47.87M | $47.87M | $47.87M | $12.50M | $12.50M | $9.38M | $15.00M | $17.00M | $20.75M | $19.50M | $2.99M |
| Long-term debt | $882.65M | $979.76M | $990.90M | $1.00B | $401.06M | $403.89M | $425.30M | $423.12M | $425.01M | $368.45M | $258.94M | $206.21M |
| Total debt | $936.50M | $1.03B | $1.04B | $1.05B | $413.56M | $416.39M | $434.67M | $438.12M | $442.01M | $389.20M | $278.44M | $209.20M |
| Total liabilities | $1.68B | $1.78B | $1.66B | $1.68B | $904.40M | $813.55M | $840.73M | $778.27M | $773.77M | $773.86M | $522.59M | $457.62M |
| Shareholders' equity | $830.22M | $815.20M | $779.29M | $775.54M | $771.53M | $750.44M | $716.73M | $709.62M | $683.01M | $657.98M | $616.65M | $597.71M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $32.75M | $68.06M | -$2.89M | $9.96M | $90.90M | $16.63M | -$10.95M | $33.98M | $23.19M | $5.98M | $19.30M | $15.40M |
| Capital expenditures | $3.88M | $4.00M | $3.06M | $2.55M | $1.42M | $3.07M | $2.53M | $2.29M | $2.84M | $369.0K | $7.06M | $4.11M |
| Free cash flow | $28.87M | $64.06M | -$5.95M | $7.40M | $89.48M | $13.56M | -$13.48M | $31.69M | $20.35M | $5.61M | $12.24M | $11.30M |
| Investing cash flow | -$6.23M | -$2.84M | -$1.06M | -$534.47M | -$1.08M | -$2.39M | -$33.32M | -$8.11M | -$79.92M | -$71.04M | -$11.43M | -$34.88M |
| Financing cash flow | -$104.07M | -$15.96M | -$26.34M | $648.49M | -$8.64M | -$44.17M | -$15.27M | -$3.19M | $47.25M | $106.35M | $11.99M | -$510.0K |
| Dividends paid | $95.0K | $104.0K | $1.56M | $96.0K | $778.0K | $5.46M | $1.92M | $218.0K | $1.80M | $95.0K | $59.81M | $1.42M |
| Share repurchases | $0 | $2.80M | $15.00M | $0 | $0 | $10.60M | $900.0K | $0 | - | - | $503.0K | $150.0K |
| Stock-based compensation | $11.79M | $9.89M | $11.38M | $7.70M | $11.71M | $7.81M | $15.23M | $6.16M | $7.39M | $5.75M | $8.68M | $5.71M |
| Depreciation and amortization | $15.55M | $15.48M | $16.40M | $15.60M | $6.90M | $6.85M | $8.13M | $7.26M | $7.44M | $5.10M | $4.90M | $4.30M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 48.5% | 55.6% | 42.9% | 99.7% | 34.7% | 53.4% | 88.4% | 37.5% | 39.6% | 19.9% | 20.0% | 9.8% |
| Net income growth, YoY | 109.5% | 115.7% | - | -97.7% | -50.8% | -54.9% | - | -27.0% | 45.6% | 13.0% | - | -4.9% |
| EPS growth, YoY | 110.5% | 107.1% | - | -97.0% | -52.5% | -54.8% | - | -29.8% | 42.9% | 10.7% | - | -6.0% |
| Operating margin | 3.5% | 3.0% | 1.9% | 2.0% | 3.1% | 3.3% | 0.1% | 5.9% | 6.2% | 7.5% | -1.1% | 11.2% |
| Net margin | 2.0% | 1.5% | 0.6% | 0.0% | 1.4% | 1.1% | -1.0% | 3.4% | 3.9% | 3.7% | 3.5% | 6.3% |
| Free cash flow margin | 3.0% | 6.6% | -0.6% | 0.8% | 13.7% | 2.2% | -2.0% | 6.6% | 4.2% | 1.4% | 3.5% | 3.2% |
| Current ratio | 1.23 | 1.35 | 1.40 | 1.40 | 1.59 | 1.70 | 1.75 | 1.91 | 1.84 | 1.52 | 2.11 | 2.35 |
| Debt to equity | 1.13 | 1.26 | 1.33 | 1.35 | 0.54 | 0.55 | 0.61 | 0.62 | 0.65 | 0.59 | 0.45 | 0.35 |
Source: XBRL data Astrana Health Inc. files with the SEC, latest filing dated Aug 10, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| ASTH | $3.84B | +58.9% | $40.55M | 1.1% | $1.71B |
| GIB | C$15.91B | +8.4% | C$1.66B | 10.4% | $19.31B |
| BAH | $10.98B | -6.2% | $784.00M | 7.1% | $10.12B |
| G | $5.25B | +6.5% | $582.65M | 11.1% | $7.07B |
| FCN | $3.98B | +7.8% | $233.42M | 5.9% | $5.33B |
| RHI | $5.30B | -2.9% | $121.73M | 2.3% | $4.28B |
| EXPO | $632.46M | +12.8% | $111.77M | 17.7% | $3.99B |
| HURN | $1.86B | +12.3% | $113.54M | 6.1% | $2.63B |
| MAN | $18.92B | +7.3% | $120.30M | 0.6% | $2.07B |